Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0XAPSN)
| ADC Name |
CN110974975B C-06
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
C-06
Click to Show/Hide
|
|||||
| Organization |
Chengdu Bailidote Biological Pharmaceutical Co ltd; Sichuan Baili Pharmaceutical Co Ltd
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.56
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
Exatecan
|
Payload Info | ||||
| Payload Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Coumpound15
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
Coumpound15-Exatecan
|
|||||